Thank you, Madam Chair.
My question is for Ms. Whattam.
We know that one of the World Health Organization's proposals to speed up vaccine production is to use the COVID-19 technology access pool, or C-TAP. The C-TAP is a global mechanism for voluntarily sharing knowledge, intellectual property and data related to health technology to combat COVID-19. I don't know whether you've heard of it before.
What has been the impact of this program so far? Doesn't this tool seem sufficient to you? Is it really necessary to focus on a waiver for intellectual property? If so, is the voluntary sharing aspect already a step in the right direction?